We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic

News   Apr 22, 2008

 
Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic
 
 
 

RELATED ARTICLES

Cellphone-microchip Duo Detects HIV

News

A portable and affordable mobile diagnostic tool detects HIV viruses and monitors its management in resource-limited regions, utilizing a cellphone and nanotechnology.

READ MORE

Up-scaling Production of MiRNA-enriched Extracellular Vesicles

News

Overexpressing an miRNA precursor in cells increases the specific miRNA content in extra-cellular vesicles, a potential new mode of drug delivery vehicle.

READ MORE

10-20% of Cells in a Kidney Organoid Found to be Non-Renal

News

Single-cell transcriptomics revealed 10-20% of cells in a kidney organoid were non-renal cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE